眼科影像人工智能的基础性考量
本文由眼科影像与算法解读工作组发起,探讨基于眼结构图像开发人工智能(AI)时应遵循的生物伦理基础。文章强调,需围绕不伤害、自主和公平三项伦理原则,在AI系统的设计、验证和实施各层面与所有利益相关方协作,以在监管审批前奠定伦理基础,从而有望改善医疗可及性与质量、减少健康差异并降低成本。
要点
- AI医疗设备开发需以不伤害、自主和公平为伦理基础。
- 伦理问题的解决影响AI设计、验证和实施的所有层面。
- 多方协作社区是解决AI伦理问题、实现其潜力的关键。
核心结论
- 基于不伤害、自主和公平的伦理原则,可能为AI系统的设计、验证和实施建立生物伦理上健全的基础。
- 实现该基础有助于在监管机构审议前成功将AI引入医学,从而改善医疗可及性与质量、减少健康差异并降低成本。
研究设计与样本
- 本文为证据综述,范围涵盖眼科影像与算法解读工作组所讨论的问题总结,该工作组于2020年9月7日在眼科影像协作社区成立会议上首次 presented,随后在工作组中继续讨论。
主要发现
- AI有潜力从根本上改善医疗可及性和患者结局,同时减少差异、降低成本并增强护理团队。
- 然而,存在重大担忧;生物伦理学家、AI算法专家、美国食品药品监督管理局及其他监管机构、产业界、患者倡导团体、临床医生及其专业学会、其他提供者团体和支付方(即利益相关方)在协作社区中共同努力解决不伤害、自主和公平等基本伦理问题,对实现这一潜力至关重要。
临床怎么用
- 在AI系统的设计、验证和实施中,应 meticulous 关注不伤害、自主和公平的伦理原则。
- 应与所有利益相关方讨论这些考量,并作为有用对话的起点加以扩展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The development of artificial intelligence (AI) and other machine diagnostic systems, also known as software as a medical device, and its recent introduction into clinical practice requires a deeply rooted foundation in bioethics for consideration by regulatory agencies and other stakeholders around the globe. OBJECTIVES: To initiate a dialogue on the issues to consider when developing a bioethically sound foundation for AI in medicine, based on images of eye structures, for discussion with all stakeholders. EVIDENCE REVIEW: The scope of the issues and summaries of the discussions under consideration by the Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group, as first presented during the Collaborative Community on Ophthalmic Imaging inaugural meeting on September 7, 2020, and afterward in the working group. FINDINGS: Artificial intelligence has the potential to improve health care access and patient outcome fundamentally while decreasing disparities, lowering cost, and enhancing the care team. Nevertheless, substantial concerns exist. Bioethicists, AI algorithm experts, as well as the Food and Drug Administration and other regulatory agencies, industry, patient advocacy groups, clinicians and their professional societies, other provider groups, and payors (i.e., stakeholders) working together in collaborative communities to resolve the fundamental ethical issues of nonmaleficence, autonomy, and equity are essential to attain this potential. Resolution impacts all levels of the design, validation, and implementation of AI in medicine. Design, validation, and implementation of AI warrant meticulous attention. CONCLUSIONS AND RELEVANCE: The development of a bioethically sound foundation may be possible if it is based in the fundamental ethical principles of nonmaleficence, autonomy, and equity for considerations for the design, validation, and implementation for AI systems. Achieving such a foundation will be helpful for continuing successful introduction into medicine before consideration by regulatory agencies. Important improvements in accessibility and quality of health care, decrease in health disparities, and lower cost thereby can be achieved. These considerations should be discussed with all stakeholders and expanded on as a useful initiation of this dialogue.
引用
- Abràmoff MD, Cunningham B, Patel B, et al. Foundational Considerations for Artificial Intelligence Using Ophthalmic Images. Ophthalmology. 2021. PMID: 34478784. doi:10.1016/j.ophtha.2021.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。